Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (321-330 of 329) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 329 results.
Respiratory Medicine and Research|January 11, 2023
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length versionVincent Cottin, Philippe Bonniaud, Jacques Cadranel, et al.
The European Respiratory Journal|January 20, 2023
Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre studyFrédéric Schlemmer, Simon Valentin, Laurent Boyer, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
The Lancet. Oncology|June 17, 2020
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort studyMarina Chiara Garassino, Jennifer G Whisenant, Li-Ching Huang, et al.
The Lancet. Respiratory Medicine|September 10, 2021
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trialJean-Marc Naccache, Stéphane Jouneau, Morgane Didier, et al.
The European Respiratory Journal|November 12, 2021
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trialCendrine Godet, Francis Couturaud, Sylvain Marchand-Adam, et al.
Hepatology (Baltimore, Md.)|November 7, 2023
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factorsSabrina Sidali, Raphaël Borie, Flore Sicre de Fontbrune, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Annals of the Rheumatic Diseases|December 15, 2025
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndromeClémence David, Nadia Nathan, Eslam Al-Abadi, et al.
Pageof 33

Showing results (321-330 of 329) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 329 results.
Respiratory Medicine and Research|January 11, 2023
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length versionVincent Cottin, Philippe Bonniaud, Jacques Cadranel, et al.
The European Respiratory Journal|January 20, 2023
Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre studyFrédéric Schlemmer, Simon Valentin, Laurent Boyer, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
The Lancet. Oncology|June 17, 2020
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort studyMarina Chiara Garassino, Jennifer G Whisenant, Li-Ching Huang, et al.
The Lancet. Respiratory Medicine|September 10, 2021
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trialJean-Marc Naccache, Stéphane Jouneau, Morgane Didier, et al.
The European Respiratory Journal|November 12, 2021
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trialCendrine Godet, Francis Couturaud, Sylvain Marchand-Adam, et al.
Hepatology (Baltimore, Md.)|November 7, 2023
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factorsSabrina Sidali, Raphaël Borie, Flore Sicre de Fontbrune, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Annals of the Rheumatic Diseases|December 15, 2025
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndromeClémence David, Nadia Nathan, Eslam Al-Abadi, et al.
Pageof 33